% Expired Patents = 33.3

CIPO Patents = 6

EPO Patents = 1

Forward Citations = 203

Loading Chart...

7 inventors (with patents filed for the assignee):

Nathan Bryson (6 out of 14 patents)

Anthony John Giovinazzo (6 out of 15 patents)

Scott David Barnhart (4 out of 27 patents)

4. Michael Clinton Koons (4 out of 8 patents)

5. David Bruce Hedden (2 out of 12 patents)

6. Marc L De Somer (2 out of 7 patents)

7. Nathan John Bryson (0 patent)

8. Marc L De Somer (0 patent)

9. Marc L De Somer (0 patent)

6 patents: Sort by Forward Citations

1. 9427412 - Sublingual films (2016-08-30),

2. 9326981 - Sublingual apomorphine (2016-05-03),

3. 9283219 - Sublingual films (2016-03-15),

4. 9044475 - Sublingual apomorphine (2015-06-02),

5. 8846074 - Sublingual films (2014-09-30),

6. 8414922 - Sublingual films (2013-04-09),

Company Overview

Cynapsus Therapeutics, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative therapies for Parkinson's disease. Their lead product candidate, APL-130277, is a sublingual film of apomorphine for the treatment of off episodes in Parkinson's disease patients. The company is committed to improving the lives of individuals living with neurological disorders through advanced drug development.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

6 Patents

#239 in Toronto

#2,414 in Canada

Toronto, Canada

Cynapsus Therapeutics, Inc.

Forward Citations = 203

7 inventors:

Nathan Bryson (6 out of 14 patents)

Anthony John Giovinazzo (6 out of 15 patents)

Scott David Barnhart (4 out of 27 patents)

4. Michael Clinton Koons (4 out of 8 patents)

5. David Bruce Hedden (2 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cynapsus Therapeutics, Inc.. Retrieved from https://idiyas.com/company/cynapsus-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

6 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]